Diligence memo · auto-generated · as of July 2, 2026

Serif Health Management, Inc.

Serif Health Management, Inc. looks fair against its niche peers and is dormant on financing cadence.

DeprioritizeFinancing has gone silent well past the sector's normal cadence — treat as inactive until outside confirmation of a live operation.

Businessfiled

Serif Health Management, Inc. operates in Healthtech, based in LOS ANGELES, CA, USA; Remote. Healthcare Price Transparency APIs and Data Products

Sub-sector tags: Artificial Intelligence, Health Tech, Analytics, Healthcare, API.

Capital & rounds (filed)filed

Serif Health Management, Inc. has raised $2.0M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).

Largest single filing: $2.0M on 2021-08-10.

Most recent recorded round closed around 2021-08-10.

Valuation (modeled)modeled

Provath models Serif Health Management, Inc. at approximately $34M (range $1.7M–$198M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Fair. Modeled value is 0.74× the median modeled value of Seed Healthtech companies in 2019–2021 (180 peers) — value vs value, same stage and era. Within the normal band (74% of peer median) for its niche.

Financing rhythm & timingmixed

Last raise 4.9 yr ago; this sector typically re-raises about every 14 months.

Only one round on record and long silent — often defunct, acquired, or gone quiet.

Comparablesmixed

Capital scale ranks ahead of 38% of Healthtech peers (2138 compared).

Modeled value ranks above 54% of those peers.

Closest niche peers: Hippo Health, Inc., Primacy Health Inc., Ursa Major Natural Care, Inc., Able Health Inc., Gentem Health Inc.

Peoplefiled

2 named people on file across officers, directors and signatories.

Risks & flagsmixed

Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.